Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer

SIMPLE SUMMARY: Hormonal treatments, especially those used to treat menopause symptoms are known to increase breast cancer risk. It is thus necessary to identify new formulations with a better benefit/risk profile. The aim of this translational study was to evaluate the breast cancer risk associated...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Gallez, Anne, Blacher, Silvia, Maquoi, Erik, Konradowski, Erika, Joiret, Marc, Primac, Irina, Gérard, Céline, Taziaux, Mélanie, Houtman, René, Geris, Liesbet, Lenfant, Françoise, Marangoni, Elisabetta, Sounni, Nor Eddine, Foidart, Jean-Michel, Noël, Agnès, Péqueux, Christel
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8160902/
https://ncbi.nlm.nih.gov/pubmed/34065180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13102486
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars